INC Research Holdings, Inc. (INCR) Stake Lessened by Virtu KCG Holdings LLC

Virtu KCG Holdings LLC reduced its position in shares of INC Research Holdings, Inc. (NASDAQ:INCR) by 62.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,632 shares of the company’s stock after selling 9,438 shares during the period. Virtu KCG Holdings LLC’s holdings in INC Research Holdings were worth $329,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of INC Research Holdings by 14.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock worth $103,000 after purchasing an additional 228 shares during the last quarter. Invictus RG purchased a new stake in shares of INC Research Holdings during the 1st quarter worth $115,000. Pacad Investment Ltd. purchased a new stake in shares of INC Research Holdings during the 2nd quarter worth $123,000. Riverhead Capital Management LLC purchased a new stake in shares of INC Research Holdings during the 2nd quarter worth $128,000. Finally, Fifth Third Bancorp lifted its position in shares of INC Research Holdings by 5.4% during the 1st quarter. Fifth Third Bancorp now owns 2,904 shares of the company’s stock worth $133,000 after purchasing an additional 149 shares during the last quarter. 54.57% of the stock is owned by institutional investors and hedge funds.

Shares of INC Research Holdings, Inc. (NASDAQ:INCR) opened at 54.30 on Wednesday. The company’s 50-day moving average is $54.63 and its 200 day moving average is $53.77. The firm has a market capitalization of $2.94 billion, a price-to-earnings ratio of 33.27 and a beta of 1.34. INC Research Holdings, Inc. has a 52 week low of $40.65 and a 52 week high of $61.10.

INC Research Holdings (NASDAQ:INCR) last posted its quarterly earnings data on Thursday, July 27th. The company reported $0.64 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.64. INC Research Holdings had a net margin of 5.69% and a return on equity of 40.69%. The firm had revenue of $258.10 million for the quarter, compared to the consensus estimate of $256.76 million. During the same period in the prior year, the firm posted $0.61 EPS. The firm’s revenue was down .3% compared to the same quarter last year. Analysts anticipate that INC Research Holdings, Inc. will post $2.60 EPS for the current fiscal year.

In other news, CEO Alistair Macdonald sold 2,348 shares of the firm’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $54.60, for a total value of $128,200.80. Following the transaction, the chief executive officer now directly owns 99,453 shares in the company, valued at approximately $5,430,133.80. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Gregory S. Rush sold 41,420 shares of the firm’s stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $58.26, for a total transaction of $2,413,129.20. Following the completion of the transaction, the chief financial officer now owns 42,793 shares in the company, valued at $2,493,120.18. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 198,321 shares of company stock worth $11,550,792. Insiders own 0.24% of the company’s stock.

Several equities research analysts have recently issued reports on the stock. William Blair cut shares of INC Research Holdings from an “outperform” rating to a “market perform” rating in a research report on Tuesday, June 20th. Jefferies Group LLC lowered shares of INC Research Holdings from a “buy” rating to a “hold” rating and lifted their price target for the stock from $62.00 to $64.00 in a research note on Thursday, June 29th. TheStreet lowered shares of INC Research Holdings from a “b” rating to a “c” rating in a research note on Friday, July 28th. Zacks Investment Research upgraded shares of INC Research Holdings from a “hold” rating to a “buy” rating and set a $58.00 price target on the stock in a research note on Wednesday, September 27th. Finally, Robert W. Baird reiterated a “buy” rating and set a $67.00 price target on shares of INC Research Holdings in a research note on Monday, October 9th. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $64.22.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://ledgergazette.com/2017/10/18/inc-research-holdings-inc-incr-stake-lessened-by-virtu-kcg-holdings-llc.html.

About INC Research Holdings

INC Research H

Other institutional investors have also recently added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of INC Research Holdings by 14.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock worth $103,000 after purchasing an additional 228 shares during the last quarter. Invictus RG purchased a new stake in shares of INC Research Holdings during the 1st quarter worth $115,000. Pacad Investment Ltd. purchased a new stake in shares of INC Research Holdings during the 2nd quarter worth $123,000. Riverhead Capital Management LLC purchased a new stake in shares of INC Research Holdings during the 2nd quarter worth $128,000. Finally, Fifth Third Bancorp lifted its position in shares of INC Research Holdings by 5.4% during the 1st quarter. Fifth Third Bancorp now owns 2,904 shares of the company’s stock worth $133,000 after purchasing an additional 149 shares during the last quarter. 54.57% of the stock is owned by institutional investors and hedge funds.

Shares of INC Research Holdings, Inc. (NASDAQ:INCR) opened at 54.30 on Wednesday. The company’s 50-day moving average is $54.63 and its 200 day moving average is $53.77. The firm has a market capitalization of $2.94 billion, a price-to-earnings ratio of 33.27 and a beta of 1.34. INC Research Holdings, Inc. has a 52 week low of $40.65 and a 52 week high of $61.10.

INC Research Holdings (NASDAQ:INCR) last posted its quarterly earnings data on Thursday, July 27th. The company reported $0.64 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.64. INC Research Holdings had a net margin of 5.69% and a return on equity of 40.69%. The firm had revenue of $258.10 million for the quarter, compared to the consensus estimate of $256.76 million. During the same period in the prior year, the firm posted $0.61 EPS. The firm’s revenue was down .3% compared to the same quarter last year. Analysts anticipate that INC Research Holdings, Inc. will post $2.60 EPS for the current fiscal year.

In other news, CEO Alistair Macdonald sold 2,348 shares of the firm’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $54.60, for a total value of $128,200.80. Following the transaction, the chief executive officer now directly owns 99,453 shares in the company, valued at approximately $5,430,133.80. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Gregory S. Rush sold 41,420 shares of the firm’s stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $58.26, for a total transaction of $2,413,129.20. Following the completion of the transaction, the chief financial officer now owns 42,793 shares in the company, valued at $2,493,120.18. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 198,321 shares of company stock worth $11,550,792. Insiders own 0.24% of the company’s stock.

Several equities research analysts have recently issued reports on the stock. William Blair cut shares of INC Research Holdings from an “outperform” rating to a “market perform” rating in a research report on Tuesday, June 20th. Jefferies Group LLC lowered shares of INC Research Holdings from a “buy” rating to a “hold” rating and lifted their price target for the stock from $62.00 to $64.00 in a research note on Thursday, June 29th. TheStreet lowered shares of INC Research Holdings from a “b” rating to a “c” rating in a research note on Friday, July 28th. Zacks Investment Research upgraded shares of INC Research Holdings from a “hold” rating to a “buy” rating and set a $58.00 price target on the stock in a research note on Wednesday, September 27th. Finally, Robert W. Baird reiterated a “buy” rating and set a $67.00 price target on shares of INC Research Holdings in a research note on Monday, October 9th. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $64.22.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://ledgergazette.com/2017/10/18/inc-research-holdings-inc-incr-stake-lessened-by-virtu-kcg-holdings-llc.html.

About INC Research Holdings

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for INC Research Holdings, Inc. (NASDAQ:INCR).

Institutional Ownership by Quarter for INC Research Holdings (NASDAQ:INCR)

Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply